Advisors Asset Management Inc. increased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 26.2% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,813 shares of the company’s stock after acquiring an additional 998 shares during the period. Advisors Asset Management Inc.’s holdings in Henry Schein were worth $330,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. UMB Bank n.a. lifted its holdings in Henry Schein by 23.2% during the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company’s stock valued at $73,000 after purchasing an additional 201 shares during the last quarter. HB Wealth Management LLC lifted its holdings in Henry Schein by 1.5% during the 1st quarter. HB Wealth Management LLC now owns 15,419 shares of the company’s stock valued at $1,056,000 after purchasing an additional 226 shares during the last quarter. Allworth Financial LP lifted its holdings in Henry Schein by 24.5% during the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company’s stock valued at $78,000 after purchasing an additional 232 shares during the last quarter. Teachers Retirement System of The State of Kentucky lifted its holdings in Henry Schein by 2.5% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 9,619 shares of the company’s stock valued at $659,000 after purchasing an additional 238 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its holdings in Henry Schein by 0.5% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 53,134 shares of the company’s stock valued at $3,639,000 after purchasing an additional 243 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.
Henry Schein Stock Up 3.2%
Shares of NASDAQ:HSIC opened at $69.55 on Friday. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The company has a 50 day moving average of $69.44 and a 200-day moving average of $69.53. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The stock has a market cap of $8.43 billion, a price-to-earnings ratio of 22.44, a P/E/G ratio of 2.22 and a beta of 0.86.
Analyst Ratings Changes
HSIC has been the subject of several analyst reports. Robert W. Baird reissued a “neutral” rating and set a $72.00 price target (down from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Baird R W downgraded shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a report on Monday, July 14th. Wall Street Zen downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Sunday, September 7th. JPMorgan Chase & Co. dropped their target price on shares of Henry Schein from $80.00 to $76.00 and set an “overweight” rating for the company in a research note on Thursday, August 7th. Finally, Evercore ISI raised shares of Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 target price for the company in a research note on Tuesday, August 26th. Five analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $76.67.
View Our Latest Stock Report on HSIC
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also
- Five stocks we like better than Henry Schein
- Top Biotech Stocks: Exploring Innovation Opportunities
- High-Flyers Near Resistance: 3 Stocks to Watch for a Dip
- What to Know About Investing in Penny Stocks
- Seagate Technology Leads S&P 500: What’s Behind Its 120% Gain?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.